🇺🇸 FDA
Patent

US 10188654

Uses of pyrimido-pyridazinones to treat cancer

granted A61KA61K31/519A61K31/5377

Quick answer

US patent 10188654 (Uses of pyrimido-pyridazinones to treat cancer) held by Asana BioSciences, LLC expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Asana BioSciences, LLC
Grant date
Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/519, A61K31/5377, A61K31/541, A61K31/55